Newsroom | 2022 results

NEW YORK--(BUSINESS WIRE)--Enhanced Group Inc. (NYSE: ENHA) (“Enhanced” or the “Company”), a sports, entertainment and performance products company, today announced that it has entered into definitive exchange agreements with certain shareholders of DEAG Deutsche Entertainment AG (“DEAG”) to acquire an approximately 77% controlling interest in DEAG, a leading Berlin-headquartered live entertainment and ticketing platform operating across Europe, with a growing presence in the US. The transactio...

EDMONTON, Alberta--(BUSINESS WIRE)--Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ | TSX: ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the second quarter 2027 ending September 30, 2026. Aurora has cancelled its investor call, originally scheduled for November 12, 2026, at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time, due to the Company’s announcement on November 3, 2026, that Aurora has entered into a defin...

BARRANQUILLA, Colombia & MIAMI--(BUSINESS WIRE)--Naturmega is pleased to celebrate the launch of LysOmega®, introduced last week by SourceOne Global Partners at SupplySide Global 2026 in Las Vegas. This innovative formulation is the result of a multi-year collaboration in which Naturmega contributed to the development, manufacturing, and supply of a specialized molecular matrix featuring EPA and DHA bonded to phospholipids rich in lysophosphatidylcholine (LPC), through its proprietary Ruby-O® t...

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal third quarter ended October 3, 2026. Key Financial Results Third Quarter 2026 vs. Third Quarter 2025 Net sales of $206 million versus $214 million. Net loss of $(5.6) million versus $(6.5) million. Diluted EPS of $(0.30) as compared with $(0.36). Adjusted diluted EPS(1) of $(0.11) as compared with $(0.15). Adjusted EBITDA(2) of $12.1 million versus $13.8 million. Core Nutri...

HOUSTON--(BUSINESS WIRE)--SynergenX, a leading provider of hormone health and wellness services, today announced the launch of its online testosterone replacement therapy (TRT) program across Texas. Building on a decade of clinical experience and more than 500,000 patients served, SynergenX is bringing its personalized approach to hormone care directly into patients' homes. With this expansion, SynergenX is extending its established clinical model beyond physical locations, giving more men acce...

LOS ANGELES--(BUSINESS WIRE)--Herbalife Ltd. (NYSE: HLF) today reported financial results for the third quarter ended September 30, 2026: “Our third quarter results demonstrate continued progress, with strong sales growth, profitability, and cash generation, enabling us to return capital to shareholders going forward, while we continue to strengthen our business and position Herbalife for sustainable, long-term growth.” - John DeSimone, Interim CEO Highlights Third Quarter 2026 Net sales of $1....

NEW YORK--(BUSINESS WIRE)--Enhanced Group (NYSE: ENHA) today announced that various key shareholders, including Apeiron Investment Group Ltd., the family office of Enhanced Group Co-Founder Christian Angermayer, as well as Enhanced Group Co-Founder and CEO Maximilian Martin, have voluntarily agreed to extend the lock-up period on their so far locked shares until May 8, 2027. As a result, the number of existing shares scheduled to be released from contractual lock-up arrangements on November 8,...

EL SEGUNDO, Calif.--(BUSINESS WIRE)--The Beachbody Company, Inc. (NASDAQ: BODI) (“BODi” or the “Company”), the proactive wellness company delivering nutrition, supplements, and proven fitness programs that help people take control of their health inside and out, will release its third quarter 2026 results on Tuesday, November 10, 2026, after the U.S. stock market closes. The Company will host a conference call at 5:00 p.m. (Eastern Time) that day to discuss the results. The toll-free dial-in fo...

MILWAUKEE--(BUSINESS WIRE)--Sensient Technologies Corporation (NYSE: SXT), a leading provider of flavors and colors for the food, pharmaceutical, and personal care markets, today reported financial results for the third quarter ended September 30, 2026. Third Quarter Consolidated Results Reported revenue increased 10.6% to $455.8 million in the third quarter of 2026 versus last year’s third quarter results of $412.1 million. On a local currency basis(1), revenue increased 10.2%. Reported operat...

韩国首尔--(BUSINESS WIRE)--(美国商业资讯)-- 第14届国际人参研讨会（The Korean Society of Ginseng主办）公布的多项临床与临床前研究表明，红参（Panax ginsengC.A. Meyer）对改善与年龄相关的生理功能衰退具有多方面的作用。相关研究结果涵盖了氧化应激调节、睡眠质量、认知功能衰退、代谢功能障碍以及肌肉功能等多个领域。 由上海交通大学医学院Hong-Sheng Tan教授领导的研究团队，对900名40至75岁自述存在慢性疲劳及免疫功能受损、但无明显器质性疾病的中国成年人进行了评估，旨在评估补充红参对抗氧化能力和整体健康状况的影响。研究显示，作为脂质过氧化及氧化应激生物标志物的血清丙二醛（MDA）水平，在红参组中显著下降，而在安慰剂组中则有所上升。其中，40至60岁受试者的抗氧化作用最为显著，且抗氧化能力与氧化应激水平呈负相关。 在经验证的健康相关生活质量评估工具——36项简明健康状况调查表（SF-36）的八个维度中，红参组的平均得分提高了10.68分，而安慰剂组仅提高了7.13分。其中，在“生理职能”和“活力”两个维度上，两...